KPTI - Karyopharm Therapeutics Inc.
IEX Last Trade
0.6697
0.064 9.497%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:29:39 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$0.61
0.06
10.49%
Summary score
41%
Profitability
50%
Dept financing
25%
Liquidity
67%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
35.87%
Return on assets
-11.81%
Return on sales
-112.13%
Return on invested capital
724.74%
Total debt ratio
124.82%
Debt ratio change over timeo
0.25%
Current Ratio
4.38%
Quick Ratio
4.33%
Cash Position Ratio
3.16%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
33.25%
Return on assets
-13.44%
Return on sales
-94.86%
Return on invested capital
63.51%
Total debt ratio
150.1%
Debt ratio change over timeo
0.99%
Current Ratio
3.9%
Quick Ratio
3.85%
Cash Position Ratio
3.1%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
22.11%
Return on assets
-16.51%
Return on sales
-101.91%
Return on invested capital
63.06%
Total debt ratio
182.64%
Debt ratio change over time
1.75%
Current Ratio
3.04%
Quick Ratio
2.99%
Cash Position Ratio
2.27%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-46.85%
Return on assets
-110.1%
Return on sales
-189.66%
Return on invested capital
-207.31%
Total debt ratio
24.5%
Debt ratio change over time
0.25%
Current Ratio
2.98%
Quick Ratio
2.93%
Cash Position Ratio
2.18%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | KPTI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 35.87% | 13.79% | 34.47% | 7.43% |
| Return on assets | -11.81% | 2.76% | 3.15% | 5.62% |
| Return on sales | -112.13% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 724.74% | 2.36% | 5.39% | 19.77% |
| Profitability | 50% | 40% | 58% | 56% |
| Total debt ratio | 124.82% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | 0.25% | 308.97% | -6.99% | 1.18% |
| Dept financing | 25% | 43% | 18% | 5% |
| Current Ratio | 3.9% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.85% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.1% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 12% | 27% | 63% |
| Short-term ratios | KPTI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 33.25% | 13.77% | 13.25% | 3.8% |
| Return on assets | -13.44% | 2.43% | 1.89% | 3.09% |
| Return on sales | -94.86% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 63.51% | 2.14% | 3.39% | 9.18% |
| Profitability | 50% | 51% | 46% | 56% |
| Total debt ratio | 150.1% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 0.99% | 46.38% | -72.08% | 1.51% |
| Dept financing | 26% | 40% | 15% | 4% |
| Current Ratio | 3.9% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.85% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.1% | 0.36% | 1.28% | 2.93% |
| Liquididy | 64% | 11% | 30% | 74% |